Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;62(1):111-120.
doi: 10.4111/icu.20200176.

Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy

Affiliations

Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy

Michael Williams et al. Investig Clin Urol. 2021 Jan.

Abstract

Purpose: To describe the surgical technique and examine the feasibility and outcomes following robotic pelvic exenteration and extended pelvic resection for rectal and/or urological malignancy.

Materials and methods: We present a case series of seven patients with locally advanced or synchronous urological and/or rectal malignancy who underwent robotic total or posterior pelvic exenteration between 2012-2016.

Results: In total, we included seven patients undergoing pelvic exenteration or extended pelvic resection. The mean operative time was 485±157 minutes and median length of stay was 9 days (6-34 days). There was only one Clavien-Dindo complication grade 3 which was a vesicourethral anastomotic leak requiring rigid cystoscopy and bilateral ureteric catheter insertion. Eighty-five percent of patients had clear colorectal margins with a median margin of 3.5 mm (0.7-8.0 mm) while all urological margins were clear. Six out of seven patients had complete (grade 3) total mesorectal excision. Three patients experienced recurrence at a median of 22 months (21-24 months) post-operatively. Of the three recurrences, one was systemic only whilst two were both local and systemic. One patient died from complications of dual rectal and prostate cancer 31 months after the surgery.

Conclusions: We report a large series examining robotic pelvic exenteration or extended pelvic resection and describe the surgical technique involved. The robotic approach to pelvic exenteration is highly feasible and demonstrates acceptable peri-operative and oncological outcomes. It has the potential to benefit patients undergoing this highly complex and morbid procedure.

Keywords: Colorectal cancer; Minimally invasive surgical procedures; Pelvic exenteration; Prostate cancer; Surgery.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. En bloc resection combining abdominoperineal resection and cystoprostatectomy, right posterior pedicle dissection.
Fig. 2
Fig. 2. In case of ultra-low anterior resection with colo-anal anastomosis, an omental flap is inserted between the both digestive and urinary fistula. (A) First, the omental flap is tunneled posteriorly to the bladder toward the pelvis. (B) Then the omental flap is sutured anterior to the colo-anal anastomosis before performing the urethra-vesical anastomosis.

References

    1. Shin US, Nancy You Y, Nguyen AT, Bednarski BK, Messick C, Maru DM, et al. Oncologic outcomes of extended robotic resection for rectal cancer. Ann Surg Oncol. 2016;23:2249–2257. - PubMed
    1. Chen W, Li Q, Qiu P, Jiang L, Fu Z, Fan Y, et al. Comparison of perioperative outcomes between laparoscopic and open surgery for mid-low rectal cancer with total mesorectal excision following neoadjuvant chemoradiotherapy. J Cancer Res Ther. 2016;12(Supplement):C199–C204. - PubMed
    1. COLOR Study Group. COLOR: a randomized clinical trial comparing laparoscopic and open resection for colon cancer. Dig Surg. 2000;17:617–622. - PubMed
    1. Chen K, Cao G, Chen B, Wang M, Xu X, Cai W, et al. Laparoscopic versus open surgery for rectal cancer: a meta-analysis of classic randomized controlled trials and high-quality nonrandomized studies in the last 5 years. Int J Surg. 2017;39:1–10. - PubMed
    1. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718–1726. - PubMed

MeSH terms